News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Serious flaws in rare disorders medicine fund proposal


Serious flaws in rare disorders medicine fund proposal

Patient advocates are rallying support for submissions to Pharmac about the U-turn they have made on medicine funding for ultra-rare disorders. After repeated refusal to fund novel and expensive treatments for disorders that affect mostly just a handful of cases in New Zealand, Pharmac have announced a special $5 Million fund so they do get a chance of being funded here.

“That’s one great step forward”, says executive director of the NZ Organisation for Rare Disorders, John Forman, “but it is a long way from a serious solution to lack of access to these vital medicines”.

NZORD says the initial proposal from Pharmac suggested that the woefully inadequate budget was the major problem that would make it extremely difficult to get fair access across 7 diseases and estimated 85 patients needing treatment. “There needs to be $20 to $25 million per year invested in this area, rather than just $5 million, but we were still keen to work with Pharmac to try and ensure the most equitable distribution of the limited funds across these patient groups,” says Forman.

“However the formal consultation document shows serious flaws in the detail of the fund, which makes it even more unlikely that any of the patients will get a fair shot at treatment. These patients face triple-jeopardy in the way Pharmac has structured the criteria for the fund.”

“The first problem is the restrictive rules proposed by Pharmac, setting a higher efficacy threshold for these treatments for ultra-rare diseases, than is expected for medicines for common diseases. Secondly, Pharmac’s special committee for rare disorders has already signalled it will resist any acceptance of weaker evidence for them, even though this is invariably the case for such rare conditions. The third problem is how the paper makes it clear there will still be comparison of costs with medicines for common diseases, despite the obvious higher unit cost of development, and widespread acceptance in other jurisdictions that such treatments will not meet standard cost-effectiveness comparisons.” says Forman.

NZORD now suspects strongly that this system has been set up to fail, as reflected in the earlier assessment that the proposal was more likely a device to dampen debate over the election period, than a serious attempt to bring in an orphan drugs access programme.

NZORD is working with support groups for Muscular Dystrophy, Cystic Fibrosis, Lysosomal diseases, and Paroxysmal Nocturnal Haemoglobinuria, in an attempt to obtain subsidy of 8 new medicines for about 85 NZ patients who are currently left untreated.

Submissions on Pharmac’s consultation document close on Friday 25th July.


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Eddie Izzard: UK Comedy Legend Returns

Hailed as one of the foremost stand up comedians of his generation. Star of stage and screen. Tireless supporter of charity. Runner. Political campaigner. Fashion Icon... February 2015, Eddie Izzard will bring his massive FORCE MAJEURE world tour to New Zealand with tickets going on sale at 10am on Tuesday 28th October. More>>

Festival Starts 28 Oct: Improv Fest Makes Up New Show

For any other festival, finding out less than two weeks from showtime that half the cast of a programmed show can’t make it to New Zealand would be a nightmare. Instead, the New Zealand Improv Festival Director Jennifer O’Sullivan saw an opportunity ... More>>

NZ Music Awards Finalists: Lorde, Sol3 Mio Top 2014 Tuis Charge

Lorde has taken the music world by storm during the past year and she co-leads the 2014 Tui charge with five finalist spots. Joining her is newcomer family opera trio, Sol3 Mio. They are followed closely by Ladi6 and David Dallas, both up for four awards each. More>>

From 'Luther' Creator: Major New Zealand Crime Series For BBC

Libertine Pictures and writer Neil Cross have teamed up with leading international TV producer Carnival Films to develop a major new crime series set in Rotorua. Libertine will develop the contemporary drama series with Carnival, producer of internationally-acclaimed British period drama Downton Abbey, for the BBC. More>>

ALSO:

Family Statement: Death Of Ewen Gilmour

“Ewen was a much loved and cherished member of our family, he was a larger than life character and by his very nature was kind, generous and always giving of his time to those who asked for his help." More>>

ALSO:

Auckland: St. Jerome's Laneway Festival - Line-Up Announced

Traversing seven cities and three countries, the festival has well and truly settled into its home in each state. From the grassy knolls and towering silos at home in Auckland, to the sparkling backdrop of the Maribyrnong... More>>

Scoop Review Of Books: No Longer An Island

Simon Nathan reviews 'Zealandia: Our Continent Revealed': The idea that New Zealand is part of a large submerged continent is not new... There was renewed interest in the extent of offshore New Zealand from the 1970s onwards with the start of offshore drilling for oil and gas, and this was given impetus by a UN agreement which allowed countries to claim an Extended Continental Shelf (ECS). More>>

Art: Simon Denny Recreates Kim Dotcom’s Personal Effects

Who owns what? How has the internet changed our relation to the world? These are two of the many questions Simon Denny raises in the latest exhibition at the Adam Art Gallery, opening on Saturday 4 October. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news